PBE | Invesco Dynamic Biotechnology & Genome ETF Overview

(Stock Exchange: AMEX)

Day's Range	67.81 - 69.14
52 Week Range	59.32 - 72.84
Beta	0.79
Implied Volatility	18.00%
IV Rank	22.83%
Day's Volume	15,490
Average Volume	6,180
Shares Outstanding	4,550,000
Inception Date	2005-06-23

Assets	261,125,400
Asset Class	Equity
Expense Ratio	0.59
P/E Ratio	23.96
EPS	2.88
Dividend Yield	0.05%
Dividend Per Share	0.03
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

*Chart delayed

Watching at PBE technicals we can see that long-term trend is bullish, while middle-term trend is bearish, but short-term trend is bullish. More technicals details can be found on PBE Technicals page.